NO305754B1 - Substituerte cykloheksanolestere, deres anvendelse ved fremstilling av preparater for behandling av sykdommer samt farmas°ytiske preparater inneholdende esterene - Google Patents
Substituerte cykloheksanolestere, deres anvendelse ved fremstilling av preparater for behandling av sykdommer samt farmas°ytiske preparater inneholdende estereneInfo
- Publication number
- NO305754B1 NO305754B1 NO950564A NO950564A NO305754B1 NO 305754 B1 NO305754 B1 NO 305754B1 NO 950564 A NO950564 A NO 950564A NO 950564 A NO950564 A NO 950564A NO 305754 B1 NO305754 B1 NO 305754B1
- Authority
- NO
- Norway
- Prior art keywords
- esters
- opt
- diseases
- preparation
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4404848A DE4404848A1 (de) | 1994-02-16 | 1994-02-16 | Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO950564D0 NO950564D0 (no) | 1995-02-15 |
| NO950564L NO950564L (no) | 1995-08-17 |
| NO305754B1 true NO305754B1 (no) | 1999-07-19 |
Family
ID=6510346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO950564A NO305754B1 (no) | 1994-02-16 | 1995-02-15 | Substituerte cykloheksanolestere, deres anvendelse ved fremstilling av preparater for behandling av sykdommer samt farmas°ytiske preparater inneholdende esterene |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US5567725A (pl) |
| EP (1) | EP0672660B1 (pl) |
| JP (1) | JPH07258220A (pl) |
| KR (1) | KR100360128B1 (pl) |
| CN (1) | CN1051298C (pl) |
| AT (1) | ATE309222T1 (pl) |
| AU (1) | AU679305B2 (pl) |
| CA (1) | CA2142556A1 (pl) |
| CZ (1) | CZ290065B6 (pl) |
| DE (2) | DE4404848A1 (pl) |
| ES (1) | ES2250966T3 (pl) |
| FI (1) | FI950649A (pl) |
| HU (1) | HUT73631A (pl) |
| IL (1) | IL112655A (pl) |
| NO (1) | NO305754B1 (pl) |
| NZ (1) | NZ270490A (pl) |
| PL (1) | PL178970B1 (pl) |
| RU (1) | RU2135465C1 (pl) |
| SG (1) | SG46690A1 (pl) |
| TW (1) | TW295578B (pl) |
| ZA (1) | ZA951220B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002096426A1 (en) * | 2001-05-25 | 2002-12-05 | Bristol-Myers Squibb Company | Hydantion derivatives as inhibitors of matrix metalloproteinases |
| WO2013134562A1 (en) | 2012-03-09 | 2013-09-12 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| CA2894281C (en) | 2012-12-20 | 2021-04-20 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| PE20160880A1 (es) | 2013-09-06 | 2016-09-22 | Inception 2 Inc | Compuestos de triazolona y usos de los mismos |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4202184A1 (de) * | 1992-01-28 | 1993-07-29 | Hoechst Ag | Substituierte salicylaldehyde zur behandlung von krankheiten |
| TW255880B (pl) * | 1992-09-09 | 1995-09-01 | Hoechst Ag | |
| TW399041B (en) * | 1992-09-09 | 2000-07-21 | Hoechst Ag | Substituted cyclohexane derivatives, the preparation and the use for treating diseases |
-
1994
- 1994-02-16 DE DE4404848A patent/DE4404848A1/de not_active Withdrawn
-
1995
- 1995-01-11 TW TW084100195A patent/TW295578B/zh active
- 1995-02-09 DE DE59511025T patent/DE59511025D1/de not_active Expired - Fee Related
- 1995-02-09 SG SG1996008408A patent/SG46690A1/en unknown
- 1995-02-09 EP EP95101747A patent/EP0672660B1/de not_active Expired - Lifetime
- 1995-02-09 AT AT95101747T patent/ATE309222T1/de not_active IP Right Cessation
- 1995-02-09 ES ES95101747T patent/ES2250966T3/es not_active Expired - Lifetime
- 1995-02-14 RU RU95101840/04A patent/RU2135465C1/ru not_active IP Right Cessation
- 1995-02-14 CZ CZ1995379A patent/CZ290065B6/cs unknown
- 1995-02-14 US US08/388,511 patent/US5567725A/en not_active Expired - Fee Related
- 1995-02-14 NZ NZ270490A patent/NZ270490A/en unknown
- 1995-02-14 AU AU12255/95A patent/AU679305B2/en not_active Ceased
- 1995-02-14 CN CN95101511A patent/CN1051298C/zh not_active Expired - Fee Related
- 1995-02-14 FI FI950649A patent/FI950649A/fi unknown
- 1995-02-15 ZA ZA951220A patent/ZA951220B/xx unknown
- 1995-02-15 KR KR1019950002773A patent/KR100360128B1/ko not_active IP Right Cessation
- 1995-02-15 HU HU9500456A patent/HUT73631A/hu unknown
- 1995-02-15 PL PL95307284A patent/PL178970B1/pl not_active IP Right Cessation
- 1995-02-15 CA CA002142556A patent/CA2142556A1/en not_active Abandoned
- 1995-02-15 NO NO950564A patent/NO305754B1/no not_active IP Right Cessation
- 1995-02-15 JP JP7026359A patent/JPH07258220A/ja not_active Abandoned
- 1995-02-15 IL IL11265595A patent/IL112655A/xx not_active IP Right Cessation
-
1996
- 1996-07-19 US US08/684,240 patent/US5629311A/en not_active Expired - Fee Related
- 1996-12-11 US US08/763,364 patent/US5719170A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO882608D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer. | |
| ES2123287T3 (es) | Derivados 3-benzoil benzofuranicos como antagonistas de la hormona tiroidea. | |
| NO924650L (no) | Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse | |
| AU692090B2 (en) | Novel 4,6-diarylpyrimidine derivatives and salts thereof | |
| DK158089D0 (da) | 2-(heterocyclylthio)-carbapenemderivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som antibiotika | |
| CA2136553A1 (en) | 7-(2-aminoethyl)-Benzothiazolones | |
| RU95105435A (ru) | N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства | |
| NO178261C (no) | Substituerte diaminoftalimider og analoger, farmasöytiske preparater inneholdende dem samt deres anvendelse i medikamenter | |
| NO305754B1 (no) | Substituerte cykloheksanolestere, deres anvendelse ved fremstilling av preparater for behandling av sykdommer samt farmas°ytiske preparater inneholdende esterene | |
| NO975094L (no) | Vinylpyrrolidoncefalosporinderivater | |
| EP0299493A3 (en) | N-û(2-oxopyrrolidin-1-yl)-acetyl¨piperazine derivatives and drug for senile dementia | |
| GEP20043181B (en) | Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| DK148288A (da) | N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne | |
| DK0420798T3 (da) | Antimikrobielle præparater | |
| ES2063266T3 (es) | 4,5,6,11-tetrahidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas y 6,11-dihidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas. | |
| ES8302719A1 (es) | Un procedimiento para preparar compuestos de cefem | |
| ES8404343A1 (es) | Un procedimiento para la prepracion de nuevos derivados de 1,4-diaminociclitol. | |
| DE69312322D1 (de) | Cephem verbindungen mit antimicrobizide eigenschaften | |
| IT1241928B (it) | Composizione oftalmica per l'uso nel mantenimento della midriasi oculare | |
| RU94038051A (ru) | Гетероциклические производные, способ их получения, фармацевтическая композиция и способ лечения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |